Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Liver Neoplasms × Oxaliplatin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 62 Stomach Neoplasms 53 Rectal Neoplasms 35 Colonic Neoplasms 28 Pancreatic Neoplasms 23 Esophageal Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 19 Adenocarcinoma 19 Neoplasms 17 Cholangiocarcinoma 15 Neoplasm Metastasis 12 Adenocarcinoma Of Esophagus 12 Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 9 Biliary Tract Neoplasms 9 Gastrointestinal Neoplasms 8 Gallbladder Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Locally Advanced Rectal Cancer 5 Recurrence 4 Lymphoma 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Carcinoma 4 Bile Duct Neoplasms 4 Advanced Solid Tumors 4 Triple Negative Breast Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

Bevacizumab 11 durvalumab 10 Nivolumab 8 pembrolizumab 7 lenvatinib 6 fludarabine 6 Cyclophosphamide 6 tremelimumab 5 atezolizumab 5 Sorafenib 4 Radiosurgery 4 Cisplatin 4 regorafenib 3 Ipilimumab 3 Gemcitabine 3 toripalimab 2 fludarabine phosphate 2 camrelizumab 2 apatinib 2 Riluzole 2 Radiotherapy 2 Magnetic Resonance Imaging 2 Lidocaine 2 zimberelimab 1 trastuzumab deruxtecan 1 tocilizumab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 ropidoxuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡